- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06794983
Calls and Coordination for Transitions of Care at Re-entry (Call2Care)
March 11, 2026 updated by: University of Wisconsin, Madison
Health Systems Innovations for Supporting Transitions of Care for Incarcerated People Living With Substance Use Disorders
The goal of this clinical trial is to learn if a short program for people being released from prison can help connect them to medical care. The main question it aims to answer is:
- Will there be more non-emergency, outpatient clinic visits?
Researchers will compare the number of clinic visits between people who use a Nurse Case Manager (NCM) to people in enhanced usual care.
Participants will:
- Complete surveys
- Talk to a study team member 2-3 times, or talk to a study team member 2-3 times and talk to an NCM 6-11 times
Study Overview
Status
Recruiting
Conditions
Detailed Description
The objective of this clinical trial is to test the effectiveness of a transitional care program adapted to meet the healthcare needs of adults after release from prison.
The goal of the transitional care intervention being tested is to help the study participants connect to primary care within 60 days of release through weekly check-in calls.
Participants in this study are enrolled approximately 6 months before their anticipated release.
One group will receive weekly phone calls for up to 60 days post-release.
Additionally, novel, linked administrative datasets will be leveraged to enhance, contextualize, and clarify policy implications of the clinical trial results.
Study Type
Interventional
Enrollment (Estimated)
488
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maggie Chilsen
- Phone Number: 608-263-2704
- Email: mchilsen@wisc.edu
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- Recruiting
- University of Wisconsin
-
Contact:
- Maggie Chilsen
- Phone Number: 608-263-2704
- Email: mchilsen@wisc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age 18 or older
- eligibility for WI Medicaid and intention to enroll before release
- substance use history (i.e., "have you ever considered your alcohol or drug use to be a problem?"), and
- living with, or history of, a chronic medical or psychiatric condition other than substance use disorder. This is defined as ever having been diagnosed with a medical or psychiatric chronic condition, or currently taking prescription medications for a chronic condition.
- able to read, understand, and speak English.
Exclusion Criteria:
- ineligible for WI Medicaid
- no substance use history
- not living with, or no history of, chronic medical or psychiatric condition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Phone Group
Participants will receive phone calls and texts.
|
Participants meet with a study team member before they are released from prison.
Study team member calls and texts participants after they are released from prison.
|
|
Experimental: Phone + Nurse Case Manager (NCM) Group
Participants will work with a nurse case manager, who will call and text.
|
Participants meet with a NCM before they are released from prison.
Nurse case manager calls and texts participants after they are released from prison.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of participants who attend a Non-Emergency Outpatient Visit within 60 Days of Release From Prison
Time Frame: 2 months post-release, approximately 5 months on study
|
2 months post-release, approximately 5 months on study
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of participants who attend a Non-Emergency Outpatient Visit for Substance Use Disorder within 60 Days of Release From Prison
Time Frame: 2 months post-release, approximately 5 months on study
|
2 months post-release, approximately 5 months on study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Marguerite Burns, University of Wisconsin, Madison
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 19, 2025
Primary Completion (Estimated)
April 30, 2029
Study Completion (Estimated)
April 30, 2029
Study Registration Dates
First Submitted
January 23, 2025
First Submitted That Met QC Criteria
January 23, 2025
First Posted (Actual)
January 27, 2025
Study Record Updates
Last Update Posted (Actual)
March 13, 2026
Last Update Submitted That Met QC Criteria
March 11, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-1669
- A538500 (Other Identifier: UW- Madison)
- SMPH/POP HEALTH SCI/POP HLTH (Other Identifier: UW- Madison)
- 2R01DA047889-06 (U.S. NIH Grant/Contract)
- Protocol Version 11/8/2024 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Medical Conditions
-
St George Hospital, AustraliaNational Health and Medical Research Council, Australia; The University of... and other collaboratorsUnknownPersonal Health Records | Chronic Medical Conditions | Electronic Medical RecordAustralia
-
Anthony VescoNorthwestern University Feinberg School of Medicine; Substance Abuse and Mental...Not yet recruitingPosttraumatic Stress Disorders | Trauma | Posttraumatic Stress Symptoms | Chronic Medical Conditions | Chronic Medical Illness | Trauma Exposure | Chronic Medical Condition | Posttraumatic Stress | Posttraumatic Stress Disorder PTSD | Mental Health Functioning | Trauma and Stressor Related DisorderUnited States
-
Universiti Putra MalaysiaEnrolling by invitationMeals | Medical Nutrition Therapy | Chronic Kidney Disease on HemodialysisMalaysia
-
Ochsner Health SystemUnknownNormal Healthy Volunteers Without Chronic Medical ConditionsUnited States
-
University of ValenciaUnknownChronic Medical IllnessSpain
-
VA Office of Research and DevelopmentRecruitingChronic Medical ConditionsUnited States
-
MedImmune LLCCompletedHealthy or Stable Underlying Chronic Medical ConditionUnited States
-
Sohag UniversityNot yet recruitingChronic Medical DiseasesEgypt
-
University of CoimbraCompleted
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingChronic Medical ConditionUnited States
Clinical Trials on In-person visit with study team member
-
Rothman Institute OrthopaedicsUnknown
-
Mayo ClinicCompletedTelemedicine | Primary Health Care | Diagnosis | Therapeutics | Developing CountriesHonduras
-
The Hawkins FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
Cedars-Sinai Medical CenterCompletedCovid19 | Satisfaction, Patient | TelemedicineUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Supportive CareUnited States
-
Memorial University of NewfoundlandCompleted
-
Region Örebro CountyKarolinska Institutet; Örebro University, SwedenNot yet recruitingUnintended Pregnancy Prevention
-
Washington University School of MedicineTeal Health, Inc.RecruitingCervical Cancer | HPV InfectionUnited States
-
Mayo ClinicTerminatedObesityUnited States